These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31897818)

  • 1. Histotype-specific analysis of acid ceramidase expression in ovarian cancer.
    El-Balat A; Karn T; Holtrich U; Becker S; Kommoss S; Győrffy B; Anglesio MS; Huntsman DG; Drosos Z; Rody A; Gevensleben H; Hanker LC
    Virchows Arch; 2020 Jun; 476(6):855-862. PubMed ID: 31897818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
    Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
    Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.
    Ruckhäberle E; Holtrich U; Engels K; Hanker L; Gätje R; Metzler D; Karn T; Kaufmann M; Rody A
    Climacteric; 2009 Dec; 12(6):502-13. PubMed ID: 19905902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
    Woodbeck R; Kelemen LE; Köbel M
    Int J Gynecol Pathol; 2019 Nov; 38(6):568-575. PubMed ID: 30480647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients.
    Li YH; Liu HT; Xu J; Xing AY; Zhang J; Wang YW; Yin G; Gao P
    Hum Pathol; 2018 Apr; 74():156-163. PubMed ID: 29320752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.
    Sänger N; Ruckhäberle E; Györffy B; Engels K; Heinrich T; Fehm T; Graf A; Holtrich U; Becker S; Karn T
    Mol Oncol; 2015 Jan; 9(1):58-67. PubMed ID: 25131496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
    Pylväs-Eerola M; Karihtala P; Puistola U
    BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
    Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
    Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
    Fadare O; Parkash V
    Surg Pathol Clin; 2019 Jun; 12(2):529-564. PubMed ID: 31097114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer.
    Hanker LC; Karn T; Holtrich U; Gätje R; Rody A; Heinrich T; Ruckhäberle E; Engels K
    Int J Gynecol Pathol; 2013 May; 32(3):249-57. PubMed ID: 23518908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
    Le Page C; Rahimi K; Köbel M; Tonin PN; Meunier L; Portelance L; Bernard M; Nelson BH; Bernardini MQ; Bartlett JMS; Bachvarov D; Gotlieb WH; Gilks B; McAlpine JN; Nachtigal MW; Piché A; Watson PH; Vanderhyden B; Huntsman DG; Provencher DM; Mes-Masson AM
    BMC Cancer; 2018 Mar; 18(1):347. PubMed ID: 29587661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian carcinoma diagnosis: the clinical impact of 15 years of change.
    Kommoss S; Gilks CB; du Bois A; Kommoss F
    Br J Cancer; 2016 Oct; 115(8):993-999. PubMed ID: 27632374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers.
    Amano T; Chano T; Isono T; Kimura F; Kushima R; Murakami T
    World J Surg Oncol; 2019 Jan; 17(1):24. PubMed ID: 30700285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histotype classification of ovarian carcinoma: A comparison of approaches.
    Peres LC; Cushing-Haugen KL; Anglesio M; Wicklund K; Bentley R; Berchuck A; Kelemen LE; Nazeran TM; Gilks CB; Harris HR; Huntsman DG; Schildkraut JM; Rossing MA; Köbel M; Doherty JA
    Gynecol Oncol; 2018 Oct; 151(1):53-60. PubMed ID: 30121132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.